We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
+21.86%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$776M
AUM Growth
+$775M
Cap. Flow
+$719M
Cap. Flow %
92.71%
Top 10 Hldgs %
83.14%
Holding
65
New
23
Increased
3
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$662M
2
DD icon
DuPont de Nemours
DD
+$24.6M
3
KBR icon
KBR
KBR
+$13.4M
4
BSN.U
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
+$9.14M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$7.46M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$20.2M
2
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$14M
3
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
+$12M
4
OTIS icon
Otis Worldwide
OTIS
+$10.3M
5
CTEV
Claritev Corp
CTEV
+$2.33M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 58.85%
2 Materials 10.12%
3 Industrials 8.7%
4 Financials 4.97%
5 Healthcare 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
26
Hims & Hers Health
HIMS
$6.99B
$4.69M 0.6%
400,000
– –
LCID icon
27
Lucid Motors
LCID
$2.58B
$3.92M 0.51%
+40,000
New +$3.93M
SST icon
28
System1
SST
$19.8M
$3.57M 0.46%
+35,000
New +$3.56M
JCAP
29
DELISTED
Jernigan Capital, Inc.
JCAP
$3.3M 0.43%
+192,202
New +$3.08M
GLIBA
30
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$3.19M 0.41%
38,735
-152,291
-80% -$12M
CTEV
31
Claritev Corp
CTEV
$599M
$3.05M 0.39%
7,207
-5,293
-42% -$2.33M
ASTS icon
32
AST SpaceMobile
ASTS
$22.3B
$3.04M 0.39%
300,000
– –
OACB.U
33
DELISTED
Oaktree Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fourth of
OACB.U
$2.58M 0.33%
+250,000
New +$2.58M
SKIL icon
34
Skillsoft
SKIL
$78.7M
$2.15M 0.28%
10,000
– –
ADV icon
35
Advantage Solutions
ADV
$399M
$1.52M 0.2%
6,000
– –
CMAX
36
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.08M 0.14%
+3,333
New +$1.02M
BMY.RT
37
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.07M 0.14%
526,681
+109,888
+26% +$314K
CLOVW
38
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$849K 0.11%
+216,666
New +$678K
OPENW
39
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$584K 0.08%
+100,000
New +$359K
LCAHW
40
DELISTED
Landcadia Holdings II, Inc. Warrant
LCAHW
$581K 0.07%
109,300
-108,000
-50% -$472K
SFTW.WS
41
DELISTED
Osprey Technology Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one shar
SFTW.WS
$576K 0.07%
400,000
– –
WPF.WS
42
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
$490K 0.06%
+200,000
New +$424K
THBRW
43
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$476K 0.06%
400,000
– –
OAC.WS
44
DELISTED
Oaktree Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
OAC.WS
$387K 0.05%
133,333
– –
SCPE.WS
45
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$372K 0.05%
300,000
– –
JWS.WS
46
DELISTED
Jaws Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary
JWS.WS
$367K 0.05%
+166,666
New +$358K
SRTAW
47
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$309K 0.04%
300,000
– –
MAPSW
48
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$266K 0.03%
450,000
– –
CCXX.WS
49
DELISTED
Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex
CCXX.WS
$261K 0.03%
125,000
– –
GHIVW
50
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
$260K 0.03%
125,000
– –
1
2
3

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return

Boussard & Gavaudan Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Boussard & Gavaudan Investment Management held 65 positions worth $776M, up 147,031% from $527K the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Boussard & Gavaudan Investment Management deployed $719M of net new capital in Q3 2020, opening 23 new positions and adding to 3 existing holdings. Its largest new stake was DuPont de Nemours: 351,510 shares worth $24.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 59% of assets, up from 45% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Tiffany & Co., an estimated $20.2M trimmed.

  • Boussard & Gavaudan Investment Management's largest Q3 2020 buy was DuPont de Nemours: 351,510 shares worth $24.5M.
  • Boussard & Gavaudan Investment Management added most to Alibaba in Q3 2020, an estimated $662M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2020 reduction was Tiffany & Co., cutting an estimated $20.2M.
  • Boussard & Gavaudan Investment Management fully exited Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an in Q3 2020, selling an estimated $7.77K.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 83% of its $776M portfolio in Q3 2020.
  • Boussard & Gavaudan Investment Management opened 23 new positions and closed 9 in Q3 2020.
  • Boussard & Gavaudan Investment Management's portfolio value rose 147,031% quarter-over-quarter to $776M.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.